What We Can Offer:
• Integrated compound screening and MOA study services for epigenetic targets including METTL3/14, P300&CBP, G9a&GLP and PRMT5
• Radioligand-binding assay, including GPCR receptor-ligand binding affinity test
• Radioactive kinase assay for kinase inhibitor screen
• Uptake assays by using radio isotope method, such as glucose uptake
• GTPγS binding assays for GPCR agonists screen
• Radioimmunoassay experiment, metabolite identification experiment and other customized detection requirements
Download
